Tafovir Tablet

Introduction

Tafovir Tablet 300 mg (TDF) is an antiviral medication used primarily in the treatment of HIV-1 infection and chronic hepatitis B. It is a prodrug of tenofovir, an analog of adenosine monophosphate that works by inhibiting the reverse transcriptase enzyme in HIV and the DNA polymerase enzyme in hepatitis B virus.

Uses

TDF is used for:

Management of HIV-1 infection, usually in combination with other antiretroviral agents.
Treatment of chronic hepatitis B infection, helping to reduce viral load and liver inflammation.

Brand Name	Tafovir
Type	Tablet
Weight	300 mg
Generic	Tenofovir Disoproxil Fumarate
Manufacturer	Popular Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

TDF is converted into its active form, tenofovir diphosphate, inside cells. It inhibits the HIV-1 reverse transcriptase enzyme, which is essential for the replication of HIV-1. In hepatitis B virus, it inhibits the HBV DNA polymerase, reducing viral replication and infection.

How Long Does It Take to Work?

For HIV treatment, TDF begins to show effects on viral load within a few weeks of starting therapy, but it may take longer to achieve complete viral suppression. For hepatitis B, a significant reduction in viral load can often be seen within a few months, though long-term therapy may be necessary for sustained efficacy.

Absorption

TDF is well absorbed from the gastrointestinal tract. Its bioavailability is increased when taken with food, which can help enhance absorption and reduce gastrointestinal side effects.

Route of Elimination

TDF and its active form are primarily eliminated by the kidneys through renal excretion. A small portion is also excreted in the feces.

Dosage

The typical dosage for adults is:

For HIV-1 infection: 300 mg once daily.
For chronic hepatitis B: 300 mg once daily.

Dosage adjustments may be necessary for patients with renal impairment. Always follow specific dosing guidelines provided by a healthcare provider.

Administration

TDF is administered orally, usually as a tablet or in a fixed-dose combination with other antiretrovirals. It is recommended to take it with food to improve absorption and reduce gastrointestinal side effects.

Side Effects

Common side effects may include:

Nausea and vomiting
Diarrhea
Headache
Fatigue

Less common but serious side effects can include renal impairment, bone density loss, and lactic acidosis.

Toxicity

Toxicity can manifest as renal impairment, significant bone loss, or lactic acidosis. Regular monitoring of kidney function and bone health is recommended during treatment.

Precautions

Precautions include:

Regular monitoring of kidney function due to potential nephrotoxicity.
Assessment of bone mineral density, especially in long-term use.
Not recommended for patients with severe renal impairment without dosage adjustment.

Interaction

TDF may interact with other medications, particularly those that affect renal function or are also eliminated through the kidneys. For example:

Interactions with other antiretroviral drugs or medications that affect kidney function.
Potential interactions with drugs that affect bone metabolism.

Consult with a healthcare provider for specific drug interactions.

Disease Interaction

Use with caution in individuals with pre-existing renal conditions, bone disorders, or those at high risk for lactic acidosis. Regular monitoring is necessary to manage these risks.

Drug Interaction

Drug interactions include:

Antiretrovirals or medications that affect renal clearance.
Drugs that can affect bone density or metabolism.

Review all concurrent medications with a healthcare provider to avoid adverse interactions.

Food Interactions

Taking TDF with food can enhance absorption and minimize gastrointestinal side effects. There are no specific food interactions that require avoidance.

Pregnancy Use

TDF is categorized as a Category B drug for pregnancy, indicating that it is generally considered safe, but should be used only if clearly needed. Consult with a healthcare provider to weigh the benefits and risks during pregnancy.

Lactation Use

TDF is excreted in breast milk in small amounts. It is generally considered safe during lactation, but consult a healthcare provider to evaluate potential risks to the infant.

Acute Overdose

Acute overdose may lead to symptoms of gastrointestinal distress, renal impairment, or other adverse effects. Seek medical attention immediately if an overdose is suspected.

Contraindication

Contraindications include severe renal impairment or hypersensitivity to tenofovir or any other component of the formulation. Use with caution in patients with significant underlying renal or bone conditions.

Use Direction

Follow the prescribed dosage and administration instructions. It is important to take TDF consistently as directed and to have regular follow-ups to monitor for any adverse effects or interactions.

Storage Conditions

Store TDF in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and follow specific storage instructions provided by the manufacturer.

Volume of Distribution

The volume of distribution for TDF is approximately 0.6 L/kg, indicating its distribution throughout body tissues and fluids.

Half Life

The terminal half-life of TDF is approximately 17 hours, which supports its once-daily dosing schedule.

Clearance

TDF is primarily cleared by the kidneys. Its clearance rate can be affected by renal function, so dose adjustments may be necessary in individuals with impaired renal function.

See in details version Tafovir Tablet 300 mg also Tafovir Tablet 300 mg in bangla